Stock Screener App

無料 -

インストール

0.00

100.00% -54.65

Akero Therapeutics Inc (AKRO)

概要ニュース株価時系列オプションチェーン Financials なぜAKROが下落しているのか？ディスカッション予測

Akero Therapeutics Inc (AKRO) 最新ニュース

Growth Value: Whats the analyst consensus on Akero Therapeutics Inc2026 Action & Real-Time Sentiment Analysis - baoquankhu1.vn

Valuation Update: Is Akero Therapeutics Inc stock influenced by commodity pricesTrade Risk Assessment & Stock Portfolio Risk Management - baoquankhu1.vn

Sentiment Watch: Is Akero Therapeutics Inc backed by strong institutional buying2026 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn

What’s Driving The Super Rally In Akero Shares On Thursday Morning? - MSN

Highs Report: Why is Akero Therapeutics Inc stock going downQuarterly Risk Review & Safe Entry Point Alerts - baoquankhu1.vn

Aug Retail: Will Akero Therapeutics Inc outperform the market in YEAR2026 Weekly Recap & Daily Momentum Trading Reports - baoquankhu1.vn

Panic Selling: Can Akero Therapeutics Inc maintain its current growth rate2026 Sector Moves & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Aug Rallies: What is the earnings history of Akero Therapeutics Inc2026 Momentum & Fast Exit/Entry Strategy Plans - baoquankhu1.vn

Akero Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | 1AKRO | US00973Y1082 - marketscreener.com

HC Wainwright & Co. Downgrades Akero Therapeutics (AKRO) - MSN

Akero Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | | US00973Y1082 - marketscreener.com

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Signal Recap: How does Akero Therapeutics Inc score in quality rankings2026 Biggest Moves & Long-Term Safe Investment Ideas - baoquankhu1.vn

Published on: 2026-03-11 23:57:58 - baoquankhu1.vn

Panic Selling: What is Akero Therapeutics Incs revenue forecastWeekly Market Summary & Low Risk Profit Maximizing Plans - baoquankhu1.vn

Treasury Yields: Is Akero Therapeutics Inc stock good for income investorsEarnings Recap Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn

Understanding Momentum Shifts in (AKRO) - Stock Traders Daily

Published on: 2026-03-01 05:11:32 - baoquankhu1.vn

Aug Chart Watch: Can Akero Therapeutics Inc maintain sales growthDollar Strength & Step-by-Step Trade Execution Guides - baoquankhu1.vn

Short Covering: Does Akero Therapeutics Inc meet Warren Buffetts criteriaPortfolio Gains Summary & Risk Controlled Swing Alerts - baoquankhu1.vn

Macro Review: Is Akero Therapeutics Inc stock influenced by commodity pricesGap Down & AI Forecasted Entry/Exit Points - baoquankhu1.vn

AKRO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Is Akero Therapeutics Inc. stock a falling knife or bargain buyRecession Risk & AI Powered Market Trend Analysis - mfd.ru

Resistance Check: Can Akero Therapeutics Inc stock outperform in a bear marketJuly 2025 Selloffs & Precise Buy Zone Identification - baoquankhu1.vn

Merger Talk: Is Akero Therapeutics Inc backed by strong institutional buying2025 Short Interest & AI Based Buy and Sell Signals - baoquankhu1.vn

Is Akero Therapeutics Inc. backed by strong institutional buyingJuly 2025 Fed Impact & Stock Market Timing Techniques - mfd.ru

Akero Therapeutics (NASDAQ: AKRO) holder Janus Henderson now at 4.1% - Stock Titan

Weekly Earnings: Does Akero Therapeutics Inc have consistent dividend growthMarket Risk Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn

Growth Value: Can Solid Biosciences Inc withstand a market correctionMarket Sentiment Review & Smart Allocation Stock Reports - baoquankhu1.vn

RTW Investments exits Akero Therapeutics (AKRO), reporting 0.0% ownership - Stock Titan

Can Akero Therapeutics Inc. maintain its current growth rateJuly 2025 PreEarnings & High Yield Equity Trading Tips - mfd.ru

Pullback Watch: Should you avoid Akero Therapeutics Inc stock right now2025 Key Lessons & High Accuracy Trade Alerts - baoquankhu1.vn

What’s Akero Therapeutics Inc.’s historical returnPortfolio Performance Report & Daily Risk Controlled Trade Plans - mfd.ru

Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero - MSN

Aug Wrap: Is Akero Therapeutics Inc. stock showing strong momentumPrice Action & Safe Entry Point Alerts - mfd.ru

Can Akero Therapeutics Inc. maintain sales growthCPI Data & Daily Entry Point Trade Alerts - mfd.ru

Analyst Downgrade: Is Akero Therapeutics Inc stock good for income investors2025 Investor Takeaways & High Yield Stock Recommendations - baoquankhu1.vn

TD Cowen Initiates Coverage of Akero Therapeutics (AKRO) with Buy Recommendation - MSN

Is Akero Therapeutics Inc. stock affected by interest rate hikesJuly 2025 WrapUp & AI Powered Market Entry Strategies - mfd.ru

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Navigating Growth in Biotechnology with a 3.39% Potential Upside - DirectorsTalk Interviews

Behavioral Patterns of AKRO and Institutional Flows - Stock Traders Daily

Analyst Calls: Is Akero Therapeutics Inc stock showing strong momentumPortfolio Growth Summary & AI Powered Market Trend Analysis - baoquankhu1.vn

Aug Movers: Is Akero Therapeutics Inc. stock influenced by commodity prices2025 Support & Resistance & Momentum Based Trading Ideas - mfd.ru

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring the 3.39% Potential Upside in Biotech Innovation - DirectorsTalk Interviews

Does Akero Therapeutics Inc. have consistent dividend growth2025 Price Targets & Weekly Watchlist for Hot Stocks - mfd.ru

Investment Report: Will Akero Therapeutics Inc outperform the market in YEARJuly 2025 Analyst Calls & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Income Plays: Is INTU a stock for growth or value investorsJuly 2025 Rallies & Expert-Curated Trade Recommendations - baoquankhu1.vn

Guidance Update: What is the earnings history of Akero Therapeutics Inc2025 Volume Leaders & Safe Capital Growth Tips - baoquankhu1.vn

(AKRO) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Quarterly Trades: How does ProShares Trust ProShares UltraPro Short QQQ perform in inflationary periodsJuly 2025 Action & High Accuracy Buy Signal Tips - baoquankhu1.vn

In Vivo’s Deals Of The Year: Cast Your Vote! - Citeline News & Insights

RSI Check: Does Akero Therapeutics Inc meet Warren Buffetts criteriaJuly 2025 Momentum & Stepwise Trade Signal Guides - baoquankhu1.vn

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring Growth Potential Amid a 3.39% Upside - DirectorsTalk Interviews

Sentiment Recap: Does Akero Therapeutics Inc meet Warren Buffetts criteriaWeekly Risk Report & Smart Swing Trading Alerts - baoquankhu1.vn

Akero Therapeutics shareholders approve Novo Nordisk merger - MSN

December blockbusters push biopharma deal value to record high - BioWorld MedTech

Q4 Activity Finishes Off Stronger Biopharma M&A Year In 2025 - Citeline News & Insights

Aug Technicals: Is CKX Lands Inc a potential multi baggerMarket Activity Recap & Daily Profit Focused Stock Screening - baoquankhu1.vn

Inflation Data: Is ISPC still a buy after recent gainsJuly 2025 EndofMonth & Long-Term Safe Return Strategies - baoquankhu1.vn

Published on: 2026-01-14 06:28:29 - Bộ Nội Vụ

Insider Buy: What is Akero Therapeutics Incs revenue forecastJuly 2025 Earnings & Safe Capital Investment Plans - baoquankhu1.vn

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Navigating the Biotech’s 3.39% Potential Upside - DirectorsTalk Interviews

AKRO stock hits 52-week high, soaring to $56.86 - MSN

Why Akero Therapeutics Inc (AKRO) Is Skyrocketing So Far In 2025 - MSN

Aug Gainers: Will Akero Therapeutics Inc. stock see PE expansionFed Meeting & Daily Oversold Stock Bounce Ideas - Улправда

How Akero Therapeutics Inc. stock performs in rising dollar environmentEarnings Growth Report & Fast Entry and Exit Trade Plans - Улправда

Can Akero Therapeutics Inc. stock resist sector downturnsTrade Volume Summary & Reliable Intraday Trade Plans - Улправда

ROIV

$28.19

0.00%

MRNA

$51.16

1.95%

RPRX

$48.49

1.30%

BNTX

$91.50

0.71%

INSM

$159.90

0.15%

ONC

$315.86

1.30%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く